Læknablaðið - 15.04.1993, Blaðsíða 10

140
LÆKNABLAÐIÐ
9. Simpson JL. Baum LD, Marder R. et al. Maternal
serum alpha-fetoprotein screening: Low and high
values for detection of genetic abnormalities. Ain J
Obstet Gynecol 1986; 155: 593-7.
10. Brambati B, Simoni G, Bonachi I, et al. Fetal
chromosomal aneuploidies and maternal serum alpha-
fetoprotein levels in first trimester. Lancet 1986;
ii: 165-6.
11. Macri JN, Buchanan PD, Gold MP. Low-fetoprotein
and trisomy. Lancet 1986; ii: 405.
12. Combining Maternal Age and Semm Alpha-
Fetoprotein to Predict the Risk of Down Syndrome.
Obstet Gynecol 1986; 68: 177-80.
13. Tabor A, Larscn SO, Nielsen J, et al. Screening for
Down’s syndrome using an iso-risk curve based on
matemal age and serum alpha-fetoprotein level. Br J
Obstet Gynecol 1987; 94: 636-42.
14. Cuckle HS, Wald NJ, Thompson SG. Estimating
a woman’s risk of having a pregnancy associated
with Down’s syndrome using her age and semm
alpha-fetoprotein level. Br J Obstet Gynecol 1987;
94: 387-402.
15. Hays WL. Statistics. New York: Holt, Rinehart and
Winston, 1981.
16. Cut-offs for low MS-AFP results. Califomia alpha
fetoprotein screening program. California 1988.
17. Prolocol for Abnormal Maternal Semm Alpha-
Fetoprotein Results. The Johns Hopkins Hospital
Obstetrical Clinic. Baltimore, 1989.
18. MacDonald ML, Agner RM, Slotnic RN. Sensilivity
and specificity of screening for Down syndrome with
alpha-fetoprotein, hCG, unconjugated estriol and
maternal age. Obstet Gynecol 1991; 77: 63-8.
19. Canick JA. Screening for Down syndrome using
matemal semm alpha-fetoprotein, unconjugated estriol
and hCG. Br J Obstet Gynecol 1988; 95: 330-3.